Quest Diagnostics Incorporated (DGX)
NYSE
Closed
Oct 23, 2026
Day's Range
239.6352 wk Range
171.18Overview - DGX - Quest Diagnostics Incorporated
Key Statistics
Valuation
Enterprise Value
32.49B
P/E (Trailing)
24.09
P/E (Forward)
20.18
PEG Ratio
1.63
Price / Sales (TTM)
2.25
Price / Book
3.48
EV / EBITDA
13.78
Profitability
Gross Margin
33.74%
Profit Margin
9.53%
Operating Margin
15.46%
Return on Assets
6.62%
Return on Equity
15.31%
Ownership
Shares Outstanding
110.00M
Float
109.44M
Short % of Shares Outstanding
3.11%
Held by Insiders
0.43%
Held by Institutions
98.76%
Price stats
50-Day Avg
237.60
200-Day Avg
210.44
Dividends
Payout Ratio
26.11%
Frequency
Quarterly
Analyst Consensus
17 analysts
Average price target
$ 245.87Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - DGX - Quest Diagnostics Incorporated
Peers - DGX - Quest Diagnostics Incorporated
Peer Comparison
Compared with companies in Diagnostics & Research listed on NYSE.
Profile Summary - DGX - Quest Diagnostics Incorporated
About
Quest Diagnostics Incorporated is a healthcare diagnostics company that provides diagnostic testing and related information services. Quest Diagnostics supports physicians, hospitals, patients, health plans, employers, and government agencies with routine clinical testing, advanced specialty testing, anatomic…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
